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Purpose. The value of nodal ratios (NRs) as a prognostic variable in breast cancer is continually being demonstrated. The purpose
of this study was to use NR in patients with ≥4+ nodes to assess a correlation of NR with regional (lymph node) recurrence.
Methods. Inclusion criteria was ≥8 nodes dissected with ≥4+ nodes after breast conservation therapy. Of 1060 patients treated
from 1975 to 2003 who had a minimum of 8 nodes dissected, 273 were node+; 56 patients had ≥4+ involved nodes and were
the focus of this study. Nodal ratios were calculated for each patient and grouped into 3 categories: high (≥70%), intermediate
(40%–69%) and low (<40%).Each nodal ratio was correlated with patterns of local, regional, and distant failures and OS. Results.
Outcomes for the entire cohort were BRFS-83%, NRFS-93%, DMFS-61%, and OS 63% at 10 yrs. The OS, DMFS, and NRFS
correlated with N2 (4–9 nodes+) versus N3 (≥10+) status but did not correlate with BRFS, as expected. When evaluating NR, 18
pts had high NR (>70%). Only 3 patients experienced nodal recurrences, all within previously radiated supraclavicular ﬁelds. All
3 in-ﬁeld regional failures occurred in the N3 group of patients with NR >70%. All were treated with a single AP ﬁeld prescribed
to a dose of 46 Gy at a standard depth of 3 cm. Conclusions. In this group of N2/N3 patients treated with BCT, we were able to
identify patients at high risk for regional failures as those with high NR of >70% and ≥10+ nodes. While these ﬁndings need to
be reproduced in larger datasets, this group of patients with NR of >70% in 4 or more positive axillary lymph nodes may beneﬁt
from meticulous targeting of regional nodes, dose escalation,and/or more intensive systemic therapies.
1.Introduction
Surgical pathologic evaluation of axilla is a standard part of
themanagementofbreast-conserving therapyforbreastcan-
cer; this has both prognostic and therapeutic implications.
While the presence of axillary lymph metastasis is the single
most critical predictor of survival in breast cancer, the abso-
lute number of lymph nodes involved appears to be equally
as important. To reﬂect the importance of this fact, the 6th
edition of the AJCC/TNM Cancer Staging Manual incor-
porated major changes in the pathologic nodal staging for
breast cancertoincludethenumberoflymphnodesinvolved
(1–3+,4–9+, ≥10+) so that an increasing number of positive
nodes results in higher N-stage and overall stage [1].
Potentially confounding the value of “number of lymph
nodes involved” is the variability of total number of lymph
nodes excised or examined during axillary staging. As a re-
sult, there has been increasing interest in the use of the nodal2 ISRN Surgery
ratio as a possible prognostic factor. The nodal ratio (NR) is
deﬁned as the absolute number of positive nodes identiﬁed
divided by the total number of nodes removed and has been
used to potentially eliminate the confounding of “involved”
versus “examined” nodes. The nodal ratio has signiﬁcant
prognostic value for locoregional recurrence and survival,
with some authors suggesting that it may be even more
important than the absolute number of positive nodes [2].
Although rare, supraclavicular recurrences are diﬃcult
to salvage and are often associated with a poor prognosis
[3]. The nodal ratio has not previously, to our knowledge,
been used to predict the risk of in-ﬁeld regional recurrence
after BCT. The purpose of our study was to determine if,
in the high-risk patient population who have undergone
adequate axillary dissection, nodal ratios can help identify
a subgroup of patients that are at highest risk for nodal in-
ﬁeld recurrences so that radiation treatment modiﬁcations
can potentially be made to improve regional relapse rates in
this high-risk population.
2.Materialsand Methods
Afterobtaining IRBapproval, themedical recordsofpatients
withbreastcancerundergoingbreast-conservingsurgeryand
whole breast radiation therapy at Yale University School of
Medicine treated from 1975 to 2003 were reviewed. The
present study cohort consisted of a group of high-risk, early-
stage, invasive breast cancer patients who had a minimum
of 8 lymph nodes excised with breast-conserving surgery
followed by adjuvant radiation therapy (n = 1060). Of
this group, 273 patients were lymph-node positive, and of
these, 56 patients (20.5%) had ≥4 positive nodes. These 56
patients comprised the study cohort for the current investi-
gation.
After conservative surgery, all patients were treated with
radiation therapy using standard isocentric techniques using
6MV photons with appropriate wedges delivering a median
dose of 48Gy to the entire breast. An electron cone down
was utilized in all patients to bring the total median dose
to the tumor bed to 64Gy. Regional nodal radiation was
delivered at the discretion of the treating physician, in
accordance to the standard practices of our institution
during the time period in which the patients were treated.
The institutional policy has generally been not include the
axilla after ALND unless there is an inadequate number of
lymph nodes excised, or signiﬁcant residual tumor burden
in the axilla (as estimated by pathology or surgical/operative
report), due to the increased risk of lymphedema. Typically,
the supraclavicular fossa was treated to a median dose of
46Gy for ≥1 involved axillary node. The regional nodal
basins irradiated were evaluated as a function of nodal
ratio.
The technique for regional nodal radiation has been pre-
viously described [4] and is only brieﬂy discussed here.
External beam radiation was administered to the supraclav-
icular fossa using a separate anterior beam half-blocked at
the central axis. The ﬁeld was angled 10–15 degrees oﬀ
of the spinal cord and extended from midline medially
(at the skin surface) to the medial border of the humeral
head laterally. If the residual burden of disease in the axillary
region was thought to be high, the lateral border was
extended laterally to beyond the humeral head to encompass
the axilla. Because these patients were treated in an era
in which CT-simulation was not routinely performed, the
majority of the patients underwent traditional, ﬂuoroscopic
simulation, and the supraclavicular ﬁeld dose was speciﬁed
to a standard depth of 3cm in all patients.
Nodal ratios (NRs) were calculated for each patient as
follows: absolute number of lymph nodes involved divided
by the number of lymph nodes excised, multiplied by 100
(expressed as a percentage). Patients were grouped into three
categories: low (NR < 40%), intermediate (NR < 70% and
≥40%), and high (NR ≥ 70%).
Breast relapse-free survival was deﬁned by time to local
failure in the treated breast. Nodal relapse-free survival
was time to regional failure (axilla, supraclavicular fossa,
infraclavicular fossa, or internal mammary nodes). Disease
free survival was deﬁned by time to disease failure outside
of the local/regional area. All events were calculated from
the time of initial diagnosis to the time of the event. The
outcomes were calculated using standard life-table methods.
The nodal ratio for each patient and relevant covariables
were assembled in a database and analyzed using PRODAS,
Version 9.1 (SAS Institute, Cary, NC). All tests of statistical
signiﬁcance were two sided. P values less than .05 were
considered statistically signiﬁcant.
3.Results
AsofSeptember2006,the median followup time was7 years.
Of the 56 patients in our cohort, 29% (n = 16) were in the
low, 39% (n = 22) in the intermediate, and 32% (n = 18) in
the high NR groups, respectively. The clinical characteristics
of the entire cohort, as a function of nodal ratio distribution,
are given in Table 1.
Table 2 describestheradiationﬁeld delivery asa function
of nodal ratio. Of note, 4 patients ofthe 56 in our cohort had
only tangential breast radiation ﬁelds without any regional
nodal radiation. These patients were classiﬁed in the low
nodal ratio group (n = 3) and the intermediate nodal ratio
group (n = 1). Thus, the remainder of the 52 patients
in the cohort received supraclavicular radiation (± axillary
radiation); speciﬁcally, all patients in the high nodal ratio
group received supraclavicular radiation to a median dose
of 46Gy. As shown in Table 3, none of the patients in the
low NR group had more than 9 positive nodes identiﬁed on
axillary dissection, whereas 67% of patients in the High NR
group had 10 or more positive nodes identiﬁed.
For the entire cohort, the overall survival was 62%,
disease-free survival was 61%, breast relapse-free survival
was83%,andnodalrelapse-free survivalwas93%at10years.
The nodal ratio was predictive of nodal relapse free survival
(77% in the HNR group versus 100% in the LNR and INR
groups (P<. 05). The OS, DMFS, and NRFS correlated with
N2 (4–9 nodes+) versus N3 (≥10+) status but did not corre-
late with BRFS, as expected. While there was a trend towardISRN Surgery 3
Table 1: Patient characteristics as a function of nodal ratio.
Clinical parameter LNR
n (%)
INR
n (%)
HNR
n (%)
Total
n (100%)
Patient age
<50 years 3 (15) 11 (52) 7 (33) 21
≥50 years 13 (38) 11 (31) 11 (31) 35
Tumor size
T1 6 (21) 11 (39) 11 (39) 28
T2 10 (36) 11 (39) 7 (25) 28
Pathologic subtype
Invasive ductal 16 (31) 20 (38) 16 (31) 52
Invasive lobular 0 (0) 1 (50) 1 (50) 2
Other 0 (0) 1 (50) 1(50) 2
Estrogen status
Positive 9 (35) 11 (42) 6 (23) 26
Negative 4 (19) 8 (38) 9 (43) 21
Progesterone status
Positive 10 (39) 11 (42) 5 (19) 26
Negative 3 (17) 6 (33) 9 (50) 18
Chemotherapy
Yes 10 (63) 20 (91) 16 (89) 46
No 6 (37) 2 (9) 2 (11) 10
Abbreviations/deﬁnitions: LNR = low nodal ratio <40%; INR = Intermedi-
ate Nodal Ratio, 40%–70%; HNR = High Nodal Ratio >70%.
Table 2: Radiation treatment ﬁeld as a function of nodal ratio.
Ratio Tangents alone
n (%)
Tangents + SC
n (%)
Total
n (%)
LNR 3 (5) 13 (23) 16 (28)
INR 1 (2) 21 (38) 22 (40)
HNR 0 (0) 18 (32) 18 (32)
Total 4 (100) 52 (100) 56 (100)
Abbreviations/deﬁnitions: LNR = Low nodal ratio <40%; INR = Interme-
diate Nodal Ratio, 40%–70%; HNR = High Nodal Ratio >70%. Tangents
alone: no nodal radiation intentionally delivered. Tangents + SC∗:T a n g e n t s
with supraclavicular ﬁeld ± IM/axilla, as clinically indicated. Percentages
given as a fraction of the total cohort (n = 56).
Table 3: Number of involved nodes on axillary dissections as a
function of nodal ratio.
Number of involved lymph nodes
4–9 + nodal group
n
≥10 + nodal group
n
Total
n
LNR 16 0 16
INR 14 8 22
HNR 6 12 18
Total 36 20 56
Abbreviations/deﬁnitions:LNR=lownodalratio<40%;INR=intermediate
nodal ratio, 40%–70%; HNR = high nodal ratio >70%. n = number of
patients in each nodal group. Percentages given as a fraction of the total
cohort (n = 56).
poorer overall survival and disease-free survival in the HNR
group, the diﬀerences were not statistically signiﬁcant.
Table 4: Nodal recurrence as a function of nodal ratio.
Ratio Axilla
n (%)
SC
n (%)
IM
n (%)
Total
n (%)
LNR 0 (0) 0 (0) 0 (0) 0 (0)
LNR 0 (0) 0 (0) 0 (0) 0 (0)
HNR 0 (0) 3 (100) 0 (0) 3 (100)
Total 0 (0) 3 (100) 0 (0) 3 (100)
Abbreviations/deﬁnitions:LNR=lownodalratio<40%;INR =intermediate
Nodal Ratio, 40%–70%; HNR = high nodal ratio >70%. SC = supraclavicu-
lar recurrence; IM = internal mammary recurrence. All patients with nodal
relapse received supraclavicular radiation. Percentages given as a fraction of
total nodal relapses (n = 3).
Three of the 56 patients had regional nodal relapses; all
3 nodal recurrences were in the supraclavicular fossa in
patients with high nodal ratios (Table 4). Therefore, the 7%
nodal relapse rate was due solely to supraclavicular relapses,
with no axillary orinternal mammary relapses. All3 regional
recurrenceshadbeentreatedwithasingleAPﬁeldprescribed
to a dose of 46Gy at 3cm, as described above. In this group
of patients with high nodal ratios, the regional relapse rate in
the treated supraclavicular fossa at 5 years was 35%.
4.Discussion
The absolutenumberofpositive lymphnodesdissected from
the axilla is currently recognized as the most signiﬁcant
predictorofsurvival in breast cancer[5–8].Itis intuitivethat
the fewer the number of lymph nodes removed in dissection
oftheaxilla,thelessreliablethispredictorwillbe,withsignif-
icant potential for understaging and under treating. Exactly
what constitutes an “adequate” axillary dissection, however,
in terms of providing suﬃcient prognostic and therapeutic
beneﬁts, remains a topic of considerable debate. In contem-
porary series of patients with early breast cancer, when 7–10
lymph nodes are identiﬁed in the axillary specimen, fewer
than 3% of patients will experience axillary failure [3, 9, 10].
Most studies assessing the extent of dissection required to
accurately assess nodal status suggest that >10 nodes should
be examined [11]. To a certain extent, the variation in the
total numbers of “axillary nodes removed” between series of
patients reﬂects not only diﬀerences in surgical technique,
but also in the pathologists’ examination of the specimens.
The concept of the nodal ratio was developed in order
to reduce the confounding of the number of involved lymph
nodes by the extent of surgical clearance and thoroughness
of pathologic examination. By combining the “involved”
and “examined” nodes into a single value, the prognostic
implications of axillary dissection may be more reliable and
may potentially lead to better selection of patients requiring
adjuvant regional nodal therapy.In addition, forcomparison
of diﬀerent series of patients, the nodal ratio can serve as a
uniform standard value. Nodal ratio has been particularly
useful when looking at patients with 1–3 positive nodes
and/or inadequatedissections, as these have historically been
groups for whom the decision to use adjuvant radiation
therapy is considered controversial.4 ISRN Surgery
Outcomes are worse with higher numbers of positive
nodesand with highernodal ratios, with a number ofstudies
suggestingthat thelatteristhestrongerofthetwoprognostic
factors. The nodal ratio has been shown to be predictive for
breast cancer outcomes in a variety of clinical scenarios (e.g.,
early-stage and locally advanced, mastectomy and BCT, ±
chemotherapy, and/or radiation) [8, 11–17]. These studies
have found nodal ratios to be predictive of a variety of
outcome parameters including locoregional relapse, disease-
free survival (DFS), progression-free survival (PFS), cause-
speciﬁc survival (CSS),overall survival (OS),and metastasis-
free survival. Furthermore, nodal ratios have also been used
to rectify interinstitutional diﬀerences in outcomes that exist
due to variations in axillary dissection practice [18]. These
ﬁndings are reviewed in a recent comprehensive publication
of the prognostic value of nodal ratios [2].
Among the studies that have used nodal ratio as a prog-
nostic indicator, various thresholds have been used for
deﬁnitionofa“high”ratio.Ourdeﬁnitionofhighnodalratio
was similar to the publications by Tai et al., the International
Nodal Ratios Working Group, and others, that used ratios of
>50%–75% for their high nodal ratio group [2, 11]. In the
above-mentioned review of nodal ratios that included >20
clinical studies, the percentage cutoﬀs for nodal ratios varied
depending upon the outcomes being investigated and the
level of statistical signiﬁcance being sought [2]. Hence, there
has yet to be established a clear beneﬁt to the use of any one
method of grouping patients by nodal ratio over any other.
Our study suggests that high nodal ratios of >70% are
predictive of supraclavicular relapse in women with early-
stage breast cancer who have had at least 8 nodes excised on
ALND. It is important to note that while the vast majority
of these patientsreceived supraclavicularradiation, the ﬁelds
were determined clinically in the era in which these patients
were treated, with the dose prescribed routinely at a depth
of 3cm, without CT guidance, as was the convention at
our institution. More recent investigations in the CT treat-
ment planning era suggest that the depth of the supracla-
vicular nodes varies signiﬁcantly, ranging from 2.4–9.5cm
(median = 4.3cm) [19]. Given this variability in depth
and the substantial risk of supraclavicular recurrence in the
high nodal ratios risk group, meticulous attention should
be paid by the treating radiation oncologist to contouring
the location of the supraclavicular lymph nodes with careful
selection of the radiation beam energy, with consideration
given to a supraclavicular boost in high-risk patients to
ensure optimal delivery of dose to these lymph nodes at
potential risk for recurrence.
5.Conclusions
While supraclavicular fossa recurrences are rare after breast
conservation therapy, our data suggest that in patients
with 4 or more positive axillary nodes treated with tra-
ditional tangential/supraclavicular techniques, high nodal
ratios(>70%)predict forin-ﬁeld regional recurrences. While
these ﬁndings need to be reproduced in larger datasets, more
meticulous treatment planning of regional nodes, radiation
dose escalation, and/or more intensive systemic therapies in
high nodal ratio patients should be considered.
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